Innovation Pharmaceuticals Inc (IPIX)

[WhatchuTawlkinBoutWillis]

"In collaboration with the NIH/NIAID’s mycology division, Brilacidin also is to be screened in multiple fungal species to further characterize its broad-spectrum antifungal activity. Future updates are planned."

https://www.ipharminc.com/press-release/2022/12/13/innovation-pharmaceuticals-reports-new-in-vivo-antifungal-data-showing-brilacidins-potential-for-treating-fungal-keratitis

"Our observations with brilacidin in the context of acutely infectious viruses support the idea of brilacidin functioning in a broad-spectrum capacity as
a novel antiviral compound. Brilacidin has also undergone several successful clinical studies in acute bacterial skin and skin structure infections. Research and development efforts are focused on identifying optimal dosing strategies to improve brilacidin in vivo effectiveness in the form of a nasally-delivered countermeasure."

https://cbdstconference.com/wp-content/uploads/2022/09/2022CBDSTconference-abstract-363.pdf